GL1X · GenesisL1 explorer

MolNFT v1 · #36952 · protein

Human transthyretin (ttr) complexed with bivalant amyloid inhibitor (6 carbon linker)

2FLM: “Human transthyretin (ttr) complexed with bivalant amyloid inhibitor (6 carbon linker)”. X-ray diffraction, 1 ligand (6CA), 2 pockets (best druggability 0.35). MolNFT v1 #36952 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
2FLM
Type
protein
Length
228 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
6CA
Pockets
2 · best druggability 0.35

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1156% helix, 53% strandP02766
BTransthyretinprotein1136% helix, 52% strandP02766

Ligands and binding sites

  • 6CA · 4'-{6-[4-(2-carboxyphenylamino)-phenoxy]-hexyloxy}-biphenyl-4-carboxylic acid · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1840.350.7517empty
2530.260.7317empty

Interfaces

1 interface between chains.

  • A–B · 898 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 2FLM · Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (6 carbon linker) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.